Guardian Financial Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$666K Buy
555
+37
+7% +$37.8K 0.26% 46
2026
Q1
$476K Buy
518
+134
+35% +$136K 0.2% 50
2025
Q4
$413K Buy
384
+84
+28% +$80.3K 0.17% 51
2025
Q3
$229K Sell
300
-159
-35% -$118K 0.1% 61
2025
Q2
$358K Buy
459
+200
+77% +$155K 0.16% 52
2025
Q1
$214K Sell
259
-99
-28% -$82.4K 0.1% 56
2024
Q4
$277K Sell
358
-379
-51% -$314K 0.16% 46
2024
Q3
$653K Sell
737
-95
-11% -$85.4K 0.41% 35
2024
Q2
$753K Sell
832
-167
-17% -$134K 0.5% 31
2024
Q1
$778K Buy
999
+400
+67% +$285K 0.53% 31
2023
Q4
$349K Buy
599
+99
+20% +$57.8K 0.29% 38
2023
Q3
$269K Buy
+500
New +$258K 0.25% 37

Other funds holding LLY

Guardian Financial Partners's LLY Position: Q2 2026 in Review

Guardian Financial Partners increased its Eli Lilly (LLY) stake by 7.1% in Q2 2026, buying an estimated $37.8K and bringing the position to 555 shares worth $666K. The position accounts for 0.26% of the portfolio, ranked #46.

Guardian Financial Partners first reported a position in LLY in Q3 2023 and has held it in 12 quarters since. The position peaked at $778K in Q1 2024. 4,593 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Guardian Financial Partners held 555 shares of Eli Lilly worth $666K as of Q2 2026.
  • Guardian Financial Partners bought 37 Eli Lilly shares in Q2 2026, an estimated $37.8K.
  • Eli Lilly made up 0.26% of Guardian Financial Partners's portfolio in Q2 2026, its #46 holding.
  • Guardian Financial Partners first reported a position in Eli Lilly in Q3 2023 and has held it in 12 quarters since.
  • Guardian Financial Partners's Eli Lilly position peaked at $778K in Q1 2024.
  • 4,593 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Guardian Financial Partners's 13F filing for Q2 2026, filed 15 Jul 2026.